Blood Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
CardioVascular BioTherapeutics to Present at Euro-Biotech Forum
July 5th, 2007
CardioVascular BioTherapeutics, Inc. (OTCBB:CVBT) announced that it will present a session on protein angiogenesis for the treatment of cardiovascular disease at the Euro-Biotech Forum, taking place in Paris from June 26-28, 2007. The presentation, titled "New Progress in Protein Angiogenesis Therapy for Cardiovascular Disease Patients," will be given by Dr. Jack Jacobs, vice president and chief operating officer of CVBT. This presentation will provide a look at the developing field of protein therapy for the treatment of cardiovascular disease, which is the number one killer of adults worldwide. The medical industry is in serious need of new treatment options for the many...
Source: Blood Weekly (2007-07-05)
|
